MCQ Quiz: Interprofessional Communication: Present Oral/Written Plan Using Evidence

A pharmacist’s clinical knowledge is most impactful when it is communicated effectively to the healthcare team. The ability to present a clear, concise, and evidence-based oral or written plan is a “transcending concept” in modern pharmacy practice, a skill honed throughout the PharmD curriculum in courses like Patient Care 4 and the Professional Skills Labs. This core competency involves more than just stating a recommendation; it requires justifying that recommendation with high-quality evidence from guidelines and primary literature, and collaborating respectfully with other professionals. This quiz will test your knowledge on the essential elements of presenting an evidence-based plan to optimize interprofessional communication and patient care.

1. When presenting a therapeutic plan to a physician, what is the most effective way to justify your recommendation?

  • a. State that it is your personal preference.
  • b. Cite a recent, high-quality clinical practice guideline.
  • c. Mention that the recommended drug is cheaper.
  • d. Say that you learned it in a lecture.

Answer: b. Cite a recent, high-quality clinical practice guideline.

2. Which communication format is best suited for conveying an urgent recommendation over the phone to a provider?

  • a. A full SOAP note
  • b. SBAR (Situation, Background, Assessment, Recommendation)
  • c. A detailed email
  • d. A formal case presentation

Answer: b. SBAR (Situation, Background, Assessment, Recommendation)

3. The “Plan” portion of a presentation or note should always include the drug, dose, route, frequency, and what other crucial component?

  • a. The manufacturer of the drug.
  • b. The specific monitoring parameters for safety and efficacy.
  • c. The color of the tablet.
  • d. The wholesale acquisition cost.

Answer: b. The specific monitoring parameters for safety and efficacy.

4. When presenting a plan based on a landmark clinical trial, it is most helpful to state:

  • a. The full list of authors on the paper.
  • b. The journal’s impact factor.
  • c. The trial’s acronym and its main conclusion as it applies to your patient.
  • d. The statistical methods used in the trial.

Answer: c. The trial’s acronym and its main conclusion as it applies to your patient.

5. “Defending a therapeutic plan” verbally using guidelines and primary literature is a key objective for student pharmacists.

  • a. True
  • b. False

Answer: a. True

6. The “Transcending Concept – Interprofessional Communication: Present Oral/Written /Plan Using Evidence” is a specific learning module in which course?

  • a. PHA5784C Patient Care 4
  • b. PHA5104 Sterile Compounding
  • c. PHA5703 Pharmacy Law and Ethics
  • d. PHA5878C Patient Care 3

Answer: a. PHA5784C Patient Care 4

7. When communicating with a nurse about a new medication order, what information is most critical to emphasize?

  • a. The detailed medicinal chemistry of the drug.
  • b. The cost-effectiveness analysis from a recent study.
  • c. Key administration details, immediate monitoring parameters, and common, serious side effects.
  • d. The history of the drug’s development.

Answer: c. Key administration details, immediate monitoring parameters, and common, serious side effects.

8. An effective written plan in a patient’s EHR should be:

  • a. As long as possible to show effort.
  • b. Written in prose, like a story.
  • c. Concise, clear, and structured (e.g., using a numbered problem list).
  • d. Filled with personal opinions and speculation.

Answer: c. Concise, clear, and structured (e.g., using a numbered problem list).

9. If another healthcare professional disagrees with your evidence-based recommendation, the most professional response is to:

  • a. Insist they are wrong and that they must follow your plan.
  • b. Listen to their perspective, understand their reasoning, and have a collaborative discussion.
  • c. Immediately abandon your recommendation.
  • d. Complain to your supervisor about the other professional.

Answer: b. Listen to their perspective, understand their reasoning, and have a collaborative discussion.

10. What does it mean to “close the loop” after making a verbal recommendation?

  • a. To hang up the phone immediately.
  • b. To confirm that the listener understood the recommendation and what the next action step will be.
  • c. To send a follow-up email with more information.
  • d. To ask for a second opinion.

Answer: b. To confirm that the listener understood the recommendation and what the next action step will be.

11. The ability to evaluate relevant primary literature to answer drug information questions is a key skill for presenting an evidence-based plan.

  • a. True
  • b. False

Answer: a. True

12. When presenting your plan, which statement is most effective?

  • a. “We should probably start some sort of blood pressure pill.”
  • b. “Per the JNC-8 guidelines, I recommend initiating lisinopril 10 mg daily for this patient’s hypertension.”
  • c. “The patient needs lisinopril.”
  • d. “I think lisinopril is a good drug.”

Answer: b. “Per the JNC-8 guidelines, I recommend initiating lisinopril 10 mg daily for this patient’s hypertension.”

13. The “A” in a SOAP note, where you justify your plan, stands for:

  • a. Action
  • b. Administration
  • c. Assessment
  • d. Alternatives

Answer: c. Assessment

14. A key difference between an oral presentation and a written note is that an oral presentation can be:

  • a. More detailed and lengthy.
  • b. Less organized.
  • c. More interactive and tailored to the audience in real-time.
  • d. Less evidence-based.

Answer: c. More interactive and tailored to the audience in real-time.

15. Contributing patient-specific medication expertise as part of an interprofessional team is a defined Entrustable Professional Activity (EPA).

  • a. True
  • b. False

Answer: a. True

16. When presenting a plan, it is important to not only state the efficacy monitoring parameters but also the:

  • a. Cost of the monitoring test.
  • b. Safety monitoring parameters.
  • c. Name of the lab technician who will run the test.
  • d. Time of day the test should be done.

Answer: b. Safety monitoring parameters.

17. If no clinical practice guideline exists for a patient’s specific situation, what is the next best source of evidence to use?

  • a. A general internet search.
  • b. A high-quality randomized controlled trial or systematic review.
  • c. The opinion of a colleague.
  • d. The drug manufacturer’s website.

Answer: b. A high-quality randomized controlled trial or systematic review.

18. Being “succinct” in a presentation means being:

  • a. Disorganized but brief.
  • b. Brief, to the point, and clear.
  • c. Vague and non-committal.
  • d. Long-winded to show your knowledge.

Answer: b. Brief, to the point, and clear.

19. Why is it important to state the patient-specific goals of therapy in your plan?

  • a. It provides a clear target to aim for and a metric to measure therapeutic success.
  • b. It is a billing requirement.
  • c. It makes the plan longer.
  • d. It is not important to state goals.

Answer: a. It provides a clear target to aim for and a metric to measure therapeutic success.

20. The curriculum specifies that an evidence-based method of communication can include SBAR or SOAP.

  • a. True
  • b. False

Answer: a. True

21. Presenting alternatives to your primary recommendation demonstrates:

  • a. A lack of confidence in your first choice.
  • b. That you have thought through the problem comprehensively and are prepared for collaborative discussion.
  • c. That you are trying to confuse the listener.
  • d. A poor understanding of the guidelines.

Answer: b. That you have thought through the problem comprehensively and are prepared for collaborative discussion.

22. An effective oral presentation begins with:

  • a. The final recommendation.
  • b. A one-liner that summarizes the patient and the primary issue.
  • c. A list of all lab values.
  • d. The patient’s social security number.

Answer: b. A one-liner that summarizes the patient and the primary issue.

23. When documenting in the EHR, your written plan should:

  • a. Contradict what you recommended verbally.
  • b. Be vague so that you have plausible deniability.
  • c. Be clear, professional, and consistent with your verbal recommendations.
  • d. Be written in all capital letters.

Answer: c. Be clear, professional, and consistent with your verbal recommendations.

24. The best way to present evidence is to:

  • a. Read the entire abstract of the paper out loud.
  • b. Concisely synthesize the finding and apply it directly to the patient at hand.
  • c. Provide a link to the article and tell the team to read it themselves.
  • d. Only present evidence that supports your initial thought.

Answer: b. Concisely synthesize the finding and apply it directly to the patient at hand.

25. A key aspect of interprofessional communication is:

  • a. Assuming the pharmacist is always right.
  • b. Recognizing the roles, responsibilities, and expertise of each team member.
  • c. Communicating only through the EHR.
  • d. Avoiding direct conversation with physicians.

Answer: b. Recognizing the roles, responsibilities, and expertise of each team member.

26. What does it mean to apply evidence to a specific patient?

  • a. Taking general guideline recommendations and individualizing them based on the patient’s comorbidities, allergies, and organ function.
  • b. Using the exact same dose recommended in a clinical trial for every patient.
  • c. Ignoring patient-specific factors.
  • d. Only using evidence from studies that exactly match your patient’s demographics.

Answer: a. Taking general guideline recommendations and individualizing them based on the patient’s comorbidities, allergies, and organ function.

27. The use of a “fishbone” diagram can be a concise way to present what type of evidence in a written plan?

  • a. The patient’s family history.
  • b. Key lab values.
  • c. The mechanism of action of a drug.
  • d. The results of a clinical trial.

Answer: b. Key lab values.

28. Using phrases like “The evidence suggests…” or “Guidelines recommend…” is a way to:

  • a. Make your recommendation sound less confident.
  • b. Ground your plan in objective data rather than personal opinion.
  • c. Make the presentation longer.
  • d. Avoid taking responsibility for the plan.

Answer: b. Ground your plan in objective data rather than personal opinion.

29. The ultimate purpose of presenting an oral or written plan is to:

  • a. Demonstrate your intelligence.
  • b. Fulfill a course requirement.
  • c. Contribute to a collaborative decision that optimizes the patient’s care.
  • d. Ensure your recommendation is followed without question.

Answer: c. Contribute to a collaborative decision that optimizes the patient’s care.

30. The skills lab curriculum includes defending a therapeutic plan verbally.

  • a. True
  • b. False

Answer: a. True

31. A pharmacist recommends drug ‘X’ based on a guideline. A physician prefers drug ‘Y’ based on their experience. The best path forward is to:

  • a. Defer to the physician immediately.
  • b. Insist on drug ‘X’.
  • c. Have a discussion about the evidence for both, and how it applies to the specific patient, to reach a consensus.
  • d. Ask the patient to choose.

Answer: c. Have a discussion about the evidence for both, and how it applies to the specific patient, to reach a consensus.

32. When presenting your plan, non-pharmacologic recommendations should be:

  • a. Omitted to save time.
  • b. Included as part of a comprehensive care plan.
  • c. Mentioned only if the patient asks.
  • d. Presented as more important than any medication.

Answer: b. Included as part of a comprehensive care plan.

33. Answering medication-related questions using scientific literature is a defined Entrustable Professional Activity (EPA).

  • a. True
  • b. False

Answer: a. True

34. When presenting to a team, confidence comes from:

  • a. Speaking the loudest.
  • b. Being thoroughly prepared and knowing the evidence for your recommendations.
  • c. Never admitting you don’t know something.
  • d. Using complex, obscure vocabulary.

Answer: b. Being thoroughly prepared and knowing the evidence for your recommendations.

35. A good plan includes not just what to do now, but also:

  • a. What to do if the initial plan fails or causes adverse effects.
  • b. A list of all medications that should never be used.
  • c. The patient’s complete dietary history.
  • d. The pharmacist’s work schedule.

Answer: a. What to do if the initial plan fails or causes adverse effects.

36. A pharmacist’s written recommendation in the EHR serves as:

  • a. A personal reminder note only.
  • b. A legal document and a form of communication to the entire healthcare team.
  • c. A suggestion that can be ignored.
  • d. An order that nurses can act upon without a physician’s co-signature.

Answer: b. A legal document and a form of communication to the entire healthcare team.

37. If you present a plan to switch from an IV to a PO medication, the evidence you should cite is related to the drug’s:

  • a. Cost.
  • b. Oral bioavailability.
  • c. Color.
  • d. Potency.

Answer: b. Oral bioavailability.

38. The skill of designing an educational in-service presentation for staff is covered in the HIPPE curriculum.

  • a. True
  • b. False

Answer: a. True

39. Active listening is a critical part of interprofessional communication because it:

  • a. Allows you to formulate your next point while others are talking.
  • b. Shows respect and helps you understand other perspectives, leading to better collaboration.
  • c. Is a passive activity that requires no effort.
  • d. Prevents you from having to speak.

Answer: b. Shows respect and helps you understand other perspectives, leading to better collaboration.

40. A pharmacist’s plan should be:

  • a. Patient-specific
  • b. Evidence-based
  • c. Actionable
  • d. All of the above

Answer: d. All of the above

41. The level of evidence for a recommendation can be graded using systems like:

  • a. SBAR
  • b. SOAP
  • c. PICO
  • d. GRADE

Answer: d. GRADE

42. When a nurse asks you why a patient is on a certain medication, your response should be:

  • a. “Because the doctor ordered it.”
  • b. A concise, clear explanation of the drug’s indication for that specific patient.
  • c. A detailed history of the drug’s development.
  • d. “You can look it up yourself.”

Answer: b. A concise, clear explanation of the drug’s indication for that specific patient.

43. A well-presented plan can increase the healthcare team’s confidence in the pharmacist’s role.

  • a. True
  • b. False

Answer: a. True

44. What is a key difference when presenting a plan to a patient versus a physician?

  • a. You should use more medical jargon with the patient.
  • b. The evidence should be the focus of the patient discussion.
  • c. The language should be simplified, and the focus should be on what the patient needs to do and expect.
  • d. There is no difference.

Answer: c. The language should be simplified, and the focus should be on what the patient needs to do and expect.

45. Before presenting a plan, a pharmacist must first complete which steps of the Pharmacists’ Patient Care Process?

  • a. Implement and Follow-up
  • b. Collect and Assess
  • c. Plan is the first step.
  • d. None of the above.

Answer: b. Collect and Assess

46. Which of the following is an example of providing evidence for a safety monitoring parameter?

  • a. “We should check potassium levels.”
  • b. “Since lisinopril can cause hyperkalemia, I recommend checking a basic metabolic panel in one week.”
  • c. “The patient needs labs.”
  • d. “Let’s monitor for side effects.”

Answer: b. “Since lisinopril can cause hyperkalemia, I recommend checking a basic metabolic panel in one week.”

47. When presenting, it is best to anticipate questions the team might have and prepare answers in advance.

  • a. True
  • b. False

Answer: a. True

48. An effective presentation of a plan should always be:

  • a. Patient-centered.
  • b. Focused on the pharmacist’s convenience.
  • c. Based on the oldest available information.
  • d. Delivered without making eye contact.

Answer: a. Patient-centered.

49. An active learning session on presenting plans using evidence is part of which course?

  • a. PHA5784C Patient Care 4
  • b. PHA5163L Professional Skills Lab 3
  • c. PHA5781 Patient Care I
  • d. PHA5782C Patient Care 2

Answer: a. PHA5784C Patient Care 4

50. The ultimate goal of presenting an evidence-based plan is to:

  • a. Win a clinical debate.
  • b. Ensure the single best course of action is chosen and implemented for the patient’s benefit.
  • c. Show how much literature you have read.
  • d. Make the medical record more detailed.

Answer: b. Ensure the single best course of action is chosen and implemented for the patient’s benefit.

Author

  • G S Sachin Author Pharmacy Freak
    : Author

    G S Sachin is a Registered Pharmacist under the Pharmacy Act, 1948, and the founder of PharmacyFreak.com. He holds a Bachelor of Pharmacy degree from Rungta College of Pharmaceutical Science and Research and creates clear, accurate educational content on pharmacology, drug mechanisms of action, pharmacist learning, and GPAT exam preparation.

    Mail- Sachin@pharmacyfreak.com

Leave a Comment

PRO
Ad-Free Access
$3.99 / month
  • No Interruptions
  • Faster Page Loads
  • Support Content Creators